Recalls / Firms / Mylan Institutional LLC

Mylan Institutional LLC

15 FDA drug recalls on record — 9 Class I.

Date	Class	Drug	Status
2021-05-03	Class III	Thiamine Hydrochloride	Terminated
2020-08-17	Class I	Tranexamic Acid	Terminated
2020-08-17	Class I	Amiodarone Hydrochloride	Terminated
2020-07-07	Class I	Daptomycin	Terminated
2020-05-05	Class II	Aloprim	Terminated
2015-04-23	Class I	Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), pac	Terminated
2015-03-23	Class I	Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial, Rx	Terminated
2015-03-23	Class I	Gemcitabine for Injection, USP, 1 g*/vial, Lyophilized powder in a Single-Use Vial, Rx onl	Terminated
2015-03-23	Class I	Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx onl	Terminated
2015-03-18	Class I	Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x	Terminated
2015-03-18	Class I	CARBOplatin Injection 450 mg/45 mL (10 mg/mL), 45 mL packaged in a 100 mL Multi-Dose Vial,	Terminated
2015-02-18	Class II	Haloperidol Decanoate	Terminated
2015-02-18	Class II	Haloperidol Decanoate	Terminated
2015-02-11	Class III	DOXOrubicin Hydrochloride Injection, USP, 200 mg/100 mL (2 mg/mL), For IV Use Only, Steril	Terminated
2015-01-23	Class III	Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx on	Terminated